Back
AnaptysBio Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
1
ANAB
AnaptysBio
Last Price:
19.91
Seasonality Move:
1.79%
Buy
59
LGND
Ligand Pharmaceuticals
Last Price:
111.11
Seasonality Move:
12.9%
Sell
1
AnaptysBio (ANAB)
is a Sell
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $19.94. The Score for ANAB is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- ANAB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $110.15. The Score for LGND is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $19.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANAB is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $110.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.19 | Sell |
| Relative Strength Index (14 RSI): | 19.42 | Sell |
| Chaikin Money Flow: | -475564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.87 - 36.19) | Sell |
| Bollinger Bands (100): | (27.24 - 37.32) | Sell |
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 56.31 | Buy |
| Chaikin Money Flow: | 52376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.79 - 110.19) | Buy |
| Bollinger Bands (100): | (90.57 - 108.59) | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.37 | Sell |
| 20-day SMA: | 30.79 | Sell |
| 50-day SMA: | 33.97 | Sell |
| 200-day SMA: | 27.91 | Sell |
| 8-day EMA: | 25.27 | Sell |
| 20-day EMA: | 29.39 | Sell |
| 50-day EMA: | 31.96 | Sell |
| 200-day EMA: | 28.77 | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.93 | Sell |
| 20-day SMA: | 107.05 | Buy |
| 50-day SMA: | 104.45 | Buy |
| 200-day SMA: | 88.21 | Buy |
| 8-day EMA: | 109.65 | Buy |
| 20-day EMA: | 107.7 | Buy |
| 50-day EMA: | 104.48 | Buy |
| 200-day EMA: | 91.25 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.57 per share, and an increase next year of $0.03 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.84 per share.
AnaptysBio Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ligand Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||